Pulmonary Embolism Clinical Trials 2022

Browse 26 Pulmonary Embolism Medical Studies Across 162 Cities

4 Phase 3 Trial · 303 Pulmonary Embolism Clinics

Clinical TrialsPulmonary Embolism Clinical Trials 2022
Reviewed by Michael Gill, B. Sc.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

New-prescription Alertfor Venous Thromboembolism

Ann Arbor, MI
Any Age
All Sexes
The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors. Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants
Recruiting
Has No Placebo
25 Pulmonary Embolism Clinical Trials Near Me
Ann Arbor, MI
Bronx, NY
New York, NY
New York, NY
More Trial Locations
An interactive map to display trial locations for University of Michigan, Jacobi Medical Center, Columbia University Medical Center/NYPH, Lenox Hill Hospital, and 269 more locations.
Most Popular References for Pulmonary Embolism Clinical Trials
Frequency
Citation
90
Rolfson, Ola, Kate Eresian Chenok, Eric Bohm, Anne Lübbeke, Geke Denissen, Jennifer Dunn, Stephen Lyman, et al.. 2016. “Patient-reported Outcome Measures in Arthroplasty Registries”. Acta Orthopaedica. Medical Journals Sweden AB. doi:10.1080/17453674.2016.1181815.
80
“ATS Statement”. 2002. “ATS Statement”. American Journal of Respiratory and Critical Care Medicine. American Thoracic Society. doi:10.1164/ajrccm.166.1.at1102.
33
Mehran, Roxana, Sunil V. Rao, Deepak L. Bhatt, C. Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, et al.. 2011. “Standardized Bleeding Definitions for Cardiovascular Clinical Trials”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.110.009449.
30
SCHULMAN, S., C. KEARON, and the SUBCOMMITTEE ON CONTROL OF ANTICOAGULATION OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS. 2005. “Definition of Major Bleeding in Clinical Investigations of Antihemostatic Medicinal Products in Non-surgical Patients”. Journal of Thrombosis and Haemostasis. Wiley. doi:10.1111/j.1538-7836.2005.01204.x.
30
Mehran, Roxana, Sunil V. Rao, Deepak L. Bhatt, C. Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, et al.. 2011. “Standardized Bleeding Definitions for Cardiovascular Clinical Trials”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.110.009449.
20
Rudski, Lawrence G., Wyman W. Lai, Jonathan Afilalo, Lanqi Hua, Mark D. Handschumacher, Krishnaswamy Chandrasekaran, Scott D. Solomon, Eric K. Louie, and Nelson B. Schiller. 2010. “Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography”. Journal of the American Society of Echocardiography. Elsevier BV. doi:10.1016/j.echo.2010.05.010.
14
Middleton P, Shepherd E, Gomersall JC. Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2021 Mar 29;3:CD001689. doi: 10.1002/14651858.CD001689.pub4.
11
Meyer, Guy, Eric Vicaut, Thierry Danays, Giancarlo Agnelli, Cecilia Becattini, Jan Beyer-Westendorf, Erich Bluhmki, et al.. 2014. “Fibrinolysis for Patients with Intermediate-risk Pulmonary Embolism”. New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmoa1302097.
10
Kucher, Nils, Peter Boekstegers, Oliver J. Müller, Christian Kupatt, Jan Beyer-Westendorf, Thomas Heitzer, Ulrich Tebbe, et al.. 2014. “Randomized, Controlled Trial of Ultrasound-assisted Catheter-directed Thrombolysis for Acute Intermediate-risk Pulmonary Embolism”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.113.005544.
10
Kucher, Nils, Peter Boekstegers, Oliver J. Müller, Christian Kupatt, Jan Beyer-Westendorf, Thomas Heitzer, Ulrich Tebbe, et al.. 2014. “Randomized, Controlled Trial of Ultrasound-assisted Catheter-directed Thrombolysis for Acute Intermediate-risk Pulmonary Embolism”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.113.005544.
Top Hospitals for Pulmonary Embolism Clinical Trials
Location
Active Pulmonary Embolism Clinical Trials
All Time Trials for Pulmonary Embolism
First Recorded Pulmonary Embolism Trial
Trials
Henry Ford Health System, Detroit, Michigan
3
4
2016
Abelacimab for Venous Thromboembolism
, Abelacimab for Pulmonary Embolism
, Warfarin for Malignancies
Temple University Hospital, Philadelphia, Pennsylvania
3
5
2016
Abelacimab for Pulmonary Embolism
, Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism
, BEC Treatment for Pulmonary Embolism
Brigham and Women's Hospital, Boston, Massachusetts
3
21
2005
Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism
, Extended Duration Thromboprophylaxis for Pulmonary Embolism
, On-screen computerized decision support alert for Pulmonary Embolism
Massachusetts General Hospital, Boston, Massachusetts
3
15
2005
Anticoagulation for Pulmonary Embolism
, 64Cu-FBP8 for Pulmonary Embolism
, Warfarin for Malignancies
London Health Sciences Centre, London, Ontario
3
6
1998
Alteplase for Pulmonary Embolism
, Limited cancer screening + FDG PET/CT for Embolism and Thrombosis
, Warfarin for Venous Thrombosis
Top Treatments for Pulmonary Embolism Clinical Trials
Treatment Name
Active Pulmonary Embolism Clinical Trials
All Time Trials for Pulmonary Embolism
First Recorded Pulmonary Embolism Trial
Trials
Abelacimab
2
2
2022
Abelacimab for Venous Thromboembolism
, Abelacimab for Pulmonary Embolism
Anticoagulation
2
2
2020
Anticoagulation for Pulmonary Embolism
, Anticoagulation for Embolus
Alteplase
2
6
2016
Alteplase for Pulmonary Embolism
, Alteplase for Ventricular Dysfunction, Right
Warfarin
2
15
2002
Warfarin for Venous Thrombosis
, Warfarin for Malignancies
New-prescription Alert
1
1
2022
New-prescription Alert for Venous Thromboembolism
Top Cities for Pulmonary Embolism Clinical Trials
City
Active Pulmonary Embolism Clinical Trials
Top Active Site for Pulmonary Embolism Clinical Trials
Trial List
Boston, Massachusetts
11
Brigham and Women's Hospital
Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism
, Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism
, Anticoagulation for Pulmonary Embolism ... View More
New York, New York
8
Lenox Hill Hospital
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Pulmonary Embolism
, FlowTriever for Pulmonary Embolism
, Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism ... View More
Louisville, Kentucky
7
Norton Heralthcare
Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism
, Anticoagulation for Pulmonary Embolism
, Warfarin for Malignancies ... View More
Philadelphia, Pennsylvania
6
Temple University Hospital
Abelacimab for Pulmonary Embolism
, Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism
, Randomized Controlled Trial Cohort - FlowTriever Arm for Pulmonary Embolism ... View More
Ottawa, Ontario
6
Ottawa Hospital
Abelacimab for Pulmonary Embolism
, Alteplase for Pulmonary Embolism
, Limited cancer screening + FDG PET/CT for Embolism and Thrombosis ... View More
Which phases are most popular for pulmonary embolism clinical trials?
Phase
Active Pulmonary Embolism Clinical Trials
Number of Unique Treatments
Number of Active Locations
Trial List
Phase < 1
2
2
5
Aspirin for Postpartum Period
, Apixaban 2.5 milligram for Venous Thromboembolism
Phase 1
2
2
1
64Cu-FBP8 for Pulmonary Embolism
, BEC Treatment for Pulmonary Embolism
Phase 3
4
3
21
Abelacimab for Venous Thromboembolism
, Abelacimab for Pulmonary Embolism
, Alteplase for Pulmonary Embolism ... View More
Phase 4
5
4
57
Anticoagulation for Pulmonary Embolism
, Anticoagulation for Embolus
, Extended Duration Thromboprophylaxis for Pulmonary Embolism ... View More
N/A
13
13
75
New-prescription Alert for Venous Thromboembolism
, AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Pulmonary Embolism
, FlowTriever for Pulmonary Embolism ... View More
How many pulmonary embolism clinical trials are open to youth and / or seniors?
Age Group
Active Pulmonary Embolism Clinical Trials
Trial List
18+
24
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Pulmonary Embolism
, FlowTriever for Pulmonary Embolism
, Abelacimab for Venous Thromboembolism ... View More
< 65
1
Lab Panel for Pulmonary Embolism
Any Age
1
New-prescription Alert for Venous Thromboembolism
Most Recent Pulmonary Embolism Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Non-invasive hemodynamic measurements for Pulmonary Embolism
8/8/2022
N/A
New-prescription Alert for Venous Thromboembolism
8/1/2022
N/A
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Pulmonary Embolism
8/1/2022
N/A
Abelacimab for Venous Thromboembolism
7/29/2022
Phase 3
Abelacimab for Pulmonary Embolism
5/4/2022
Phase 3
Phase 3 Pulmonary Embolism Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Abelacimab for Venous Thromboembolism
7/29/2022
Phase 3
Abelacimab for Pulmonary Embolism
5/4/2022
Phase 3
Alteplase for Pulmonary Embolism
8/4/2021
Phase 3
Apixaban for Pulmonary Embolism
7/14/2017
Phase 3
Pediatric Pulmonary Embolism Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
New-prescription Alert for Venous Thromboembolism
8/1/2022
N/A
Lab Panel for Pulmonary Embolism
2/6/2020
N/A
Senior Friendly Pulmonary Embolism Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Non-invasive hemodynamic measurements for Pulmonary Embolism
8/8/2022
N/A
New-prescription Alert for Venous Thromboembolism
8/1/2022
N/A
AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Pulmonary Embolism
8/1/2022
N/A
Abelacimab for Venous Thromboembolism
7/29/2022
Phase 3
Abelacimab for Pulmonary Embolism
5/4/2022
Phase 3
Recently Completed Studies with FDA Approved Treatments for Pulmonary Embolism
Treatment
Year
Mechanism of Action
Sponsor
Active Pulmonary Embolism Clinical Trials
Ferumoxytol
2018
Ferumoxytol
Brigham and Women's Hospital
0
Edoxaban
2017
Edoxaban
Daiichi Sankyo, Inc.
1

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 4th, 2021

Last Reviewed: August 18th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Relevant Clinical Trials

Opiate Addiction Clinical Trials 2022
Bone Metastases Clinical Trials 2022
Nephrotic Syndrome Clinical Trials 2022
Nerve Pain Clinical Trials 2022
Neuropathic Pain Clinical Trials 2022
Neurofibromatosis Type 1 Clinical Trials 2022
Vestibular Schwannoma Clinical Trials 2022
Acoustic Neuroma Clinical Trials 2022
Morbid Obesity Clinical Trials 2022
Obsessive Compulsive Disorder Clinical Trials 2022
Pancreatitis Clinical Trials 2022
Pancreatitis Clinical Trials
Paraganglioma Clinical Trials 2022
Bullous Pemphigoid Clinical Trials 2022
Peyronie'S Disease Clinical Trials 2022
Peyronie Disease Clinical Trials 2022
Peritoneal Carcinomatosis Clinical Trials 2022
Peritoneal Cancer Clinical Trials 2022
Pheochromocytoma Clinical Trials 2022
Pituitary Tumor Clinical Trials 2022

Top Oncology Trials

Cancer Clinical Trials 2022
Pancreas Cancer Clinical Trials 2022
Prostate Cancer Clinical Trials 2022
Breast Cancer Clinical Trials 2022
Oncology Clinical Trials 2022
Pancreatic Cancer Clinical Trials 2022
Colon Cancer Clinical Trials 2022
Lung Cancer Clinical Trials 2022
Melanoma Clinical Trials 2022
Multiple Myeloma Clinical Trials 2022
Ovarian Cancer Clinical Trials 2022
Triple Negative Breast Cancer Clinical Trials 2022
Esophageal Cancer Clinical Trials 2022
CLL Clinical Trials 2022
Small Cell Lung Cancer Clinical Trials 2022
Leukemia Clinical Trials 2022
Mesothelioma Clinical Trials 2022
AML Clinical Trials 2022
Bladder Cancer Clinical Trials 2022
Brain Cancer Clinical Trials 2022

Popular Clinical Trials

COVID Clinical Trials 2022
Depression Clinical Trials 2022
ALS Clinical Trials 2022
Marijuana Clinical Trials 2022
Type 1 Diabetes Clinical Trials 2022
IVF Clinical Trials 2022
PTSD Clinical Trials 2022
Tinnitus Clinical Trials 2022
Diabetes Clinical Trials 2022
Coronavirus Clinical Trials 2022
Lupus Clinical Trials 2022
Psilocybin Clinical Trials 2022
Rheumatoid Arthritis Clinical Trials 2022
Multiple Sclerosis Clinical Trials 2022
Obesity Clinical Trials 2022
Psoriasis Clinical Trials 2022
Alzheimer's Disease Clinical Trials 2022
Asthma Clinical Trials 2022
Lyme Disease Clinical Trials 2022
Osteoarthritis Clinical Trials 2022
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top